Skip to main content

Featured

Markets Rebound as Hopes for Iran–U.S. Dialogue Ease Geopolitical Tensions

U.S. stock futures edged higher on Wednesday as signs of potential diplomatic movement in the Iran–U.S. standoff helped calm volatile markets. Futures tied to the S&P 500 rose about 0.3%, the Nasdaq 100 gained 0.5%, and Dow Jones Industrial Average futures added 0.2% after a turbulent prior session.  The shift in sentiment followed reports that Iran has quietly approached the United States to discuss terms for ending the escalating conflict , a development that helped cool fears of further disruption in global energy markets. This diplomatic signal contributed to a rebound after Tuesday’s sharp sell-off, when concerns over widening conflict and rising oil prices rattled investors.  The conflict, now in its fifth day, has seen continued strikes and mounting casualties, adding to market unease. Iran is preparing for the funeral of Supreme Leader Ali Khamenei, killed in recent attacks, while regional tensions remain high.  Despite the ongoing uncertainty, Wednesda...
Post a Comment
Read more

article

Labels

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine


Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.

This is the second vaccine targeting XBB.1.5 that will be available in this country.

Earlier this month, Health Canada authorized Moderna's updated mRNA vaccine.

Both Pfizer and Moderna's shots are one-dose vaccines for people five years of age and older.

Three shots of the Pfizer vaccine is recommended for children between six months and four years of age who have not received their primary series of a COVID-19 vaccine.

Health Canada says it is currently reviewing an updated non-mRNA vaccine from Novavax.

Novavax’s vaccine has been submitted for consideration for people age 12 years and older.

Labels:

Comments

Post a Comment